Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q3 2023 ▲▼ | Q4 2023 ▲▼ | Change ▲▼ | Q3 2023 ▲▼ | Q4 2023 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Entrada Therapeutics, Inc.(TRDA) | 4,425,784 | 4,425,784 | 0 | $69.93M | $66.79M | 32.82% | -$3.14M |
| Dyne Therapeutics, Inc.(DYN) | 4,951,303 | 4,951,303 | 0 | $44.36M | $65.85M | 32.36% | +$21.49M |
| iTeos Therapeutics, Inc. | 2,738,785 | 2,738,785 | 0 | $29.99M | $29.99M | 14.74% | $0 |
| Werewolf Therapeutics, Inc.(HOWL) | 4,284,172 | 4,284,172 | 0 | $9.17M | $16.54M | 8.13% | +$7.37M |
| Repare Therapeutics, Inc. | 2,242,636 | 2,242,636 | 0 | $27.09M | $16.37M | 8.04% | -$10.72M |
| Adaptimmune Therapeutics plcADR(ADAPY) | 6,287,101 | 5,555,461 | -731,640 | $4.90M | $4.41M | 2.16% | -$498.5K |
| Harpoon Therapeutics, Inc. | 0 | 313,136 | +313,136 | $0 | $3.56M | 1.75% | +$3.56M |
| Harpoon Therapeutics, Inc.Common | 313,136 | 0 | -313,136 | $1.26M | $0 | — | -$1.26M |